Implications of blood glucose, insulin resistance and β-cell function in impaired glucose tolerance

Diabetes Research and Clinical Practice

Volumn 40, Issue SUPPL., 1998, Pages

  Göke, Burkhard ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Glucotoxicity; Hyperglycemia; Insulin; Insulin action; Insulin resistance; Cell

Indexed keywords

CELL FUNCTION; CONFERENCE PAPER; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; PANCREAS ISLET BETA CELL; TARGET CELL;

EID: 0345698730     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8227(98)00037-0     Document Type: Conference Paper

References (43)

1. S. O'Rahilly, Non-insulin dependent diabetes: the gathering storm, Br. Med. J. 314 (1997) 955-959.
2. A.M. Hodge, G.K. Dowse, P.Z. Zimmet, V.R. Collins, Prevalence and secular trends in obesity in Pacific and Indian Ocean island populations, Obes. Res. 3 (Suppl. 2) (1995) 77S-87S.
3. W.C. Knowler, K.M.V. Narayan, R.L. Hanson, R.G. Nelson, P.H. Bennett, J. Tuomiletho, B. Schersten, D.J. Pettitt, Preventing non-insulin dependent diabetes, Diabetes 44 (1995) 483-488.
4. S. Lillioja, D.M. Mott, B.V. Howard, P.H. Bennett, H. Yki-Jarvinen, D. Freymond, B.L. Nyomba, B. Swinburn, C. Bogardus, Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima indians, N. Engl. J. Med. 318 (1988) 1217-1225.
5. M.F. Saad, W.C. Knowler, D.J. Pettit, R.G. Nelsom, D.M. Mott, P.H. Bennett, The natural history of impaired glucose tolerance in Pima indians, N. Engl. J. Med. 319 (1988) 1500-1506.
6. W.C. Knowler, D.J. Pettitt, M.F. Saad, P.H. Bennett, Diabetes mellitus in the Pima indians: incidence, risk factors and pathogenesis, Diabetes Metab. Rev. 6 (1990) 1-27.
7. M.F. Saad, W.C. Knowler, D.J. Pettitt, R.G. Nelson, M.A. Charles, P.H. Bennett, A two-step model for the development of non-insulin dependent diabetes, Am. J. Med. 90 (1990) 229-235.
8. S.L. Edelstein, W.C. Knowler, R.P. Bain, et al., Predictors of progression from impaired glucose tolerance to NIDDM, Diabetes 46 (1997) 701-710.
9. National Diabetes Data Group, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance, Diabetes 28 (1979) 1039-1057.
10. R.C. Eastman, C.C. Cowie, M.I. Harris, Undiagnosed diabetes or impaired glucose tolerance and cardiovascular risk, Diabetes Care 20 (1997) 127-128.
11. L.P. Lowe, K. Liu, P. Greenland, B.E. Metzger, A.R. Dyer, J. Stamler, Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men: the Chicago Heart Association Detection Project in Industry study, Diabetes Care 20 (1997) 163-169.
12. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care 20 (1997) 1183-1197.
13. J.D. Brunzell, R.P. Robertson, R.L. Lerner, W.R. Hazzard, J.W. Ensink, E.L. Bierman, D. Porte Jr., Relationship between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests, J. Clin. Endocrinol. Metab. 42 (1976) 222-229.
14. J.H. Fuller, M.J. Shipley, G. Rose, R.J. Jarrett, H. Keen, Coronary heart disease risk and impaired glucose tolerance: the Whitehall Study, Lancet i (1980) 1373-1376.
15. R. Klein, E.B. Comor, B.A. Blount, D.L. Wingard, Visual impairment and retinopathy in people with normal glucose tolerance, impaired glucose tolerance and newly diagnosed NIDDM, Diabetes Care 14 (1991) 914-918.
16. G.M. Reaven, J. Olefsky, J.U.W. Farquhar, Does hyperglycemia or hyperinsulinemia characterize the patient with chemical diabetes? Lancet i (1972) 1247-1249.
17. R.R. Little, J.D. England, H.M. Wiedmeyer, E.M. McKenzie, D.J. Pettit, W.C. Knowler, D.E. Goldstein, Relationship of glycosylated hemoglobin to oral glucose tolerance: implications for diabetes screening, Diabetes 37 (1988) 60-64.
18. R.A. DeFronzo, Classification and diagnosis of diabetes mellitus, in: R.A. DeFronzo (Ed.), Current Therapy of Diabetes Mellitus, Mosby, St. Louis, 1997, pp. 1-4.
19. D.M. Nathan, The pathophysiology of diabetic complications: how much does the glucose hypothesis explain?, Ann. Intern. Med. 124 (1996) 86-89.
20. J. Pirart, Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973, Diabetes Care 1 (1978) 168-188.
21. H.C. Knowles, The problem of the relation of the control of diabetes to the development of vascular disease, Trans. Am. Clin. Climatol. Assoc. 76 (1964) 142-147.
22. R. Klein, B.E. Klein, S.E. Moss, M.D. Davis, D.L. DeMets, Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy, J. Am. Med. Assoc. 260 (1988) 2864-2871.
23. R. Klein, Hyperglycemia and microvascular and macrovascular disease in diabetes, Diabetes Care 18 (1995) 258-268.
24. R. Klein, B.E. Klein, S.E. Moss, M.D. Davis, D.L. DeMets, The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years, Arch. Opthalmol. 102 (1984) 527-537.
25. Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus, N. Engl. J. Med. 329 (1993) 977-986.
26. Y. Ohkubo, H. Kishikawa, E. Araki, T. Miyata, S. Motoyoshi, Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study, Diabetes Res. Clin. Pract. 28 (1995) 103-117.
27. H.E. Lebovitz, Alpha-glucosidase inhibitors, Endocrin. Metab. Clin. North Am. 26 (1997) 539-551.
28. R.H. Unger, S. Grundy, Hyperglycemia as an inducer as well as a consequence of impaired islet function and insulin resistance: implications for the management of disease, Diabetologia 28 (1985) 119-121.
29. J.L. Leahy, H.E. Cooper, G.C. Weir, Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion, J. Clin. Invest. 77 (1986) 908-915.
30. L. Rosetti, Glucose 'toxicity': effect of chronic hyperglycemia on insulin action, in: D. LeRoith, S.I. Taylor, J.M. Olefsky (Eds.), Diabetes Mellitus, Lippincott-Raven, Philadelphia, PA, 1996, pp. 514-553.
31. E. Barret-Connor, Does hyperglycemia really cause coronary heart disease?, Diabetes Care 20 (1997) 1620-1623.
32. M. Laakso, Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus, Ann. Intern. Med. 124 (1996) 127-130.
33. G.M. Reaven, Role of insulin resistance in human disease, Diabetes 37 (1988) 1595-1607.
34. G.M. Reaven, Pathophysiology of insulin resistance in human disease, Physiol. Rev. 75 (1995) 473-486.
35. R. O'Doherty, D. Stein, J. Foley, Insulin resistance, Diabetologia 40 (1997) B10-B15.
36. E. Ferranini, Insulin resistance is central to the burden of diabetes, Diabetes Metab. Rev. 13 (1997) 81-86.
37. P.D. Home, Insulin resistance is not central to the burden of diabetes, Diabetes Metab. Rev. 13 (1997) 87-92.
38. R.A. DeFronzo, The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM, Diabetes 37 (1988) 667-687.
39. N.M. Kaplan, The deadly quartet, upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension, Arch. Intern. Med. 149 (1989) 1514-1520.
40. H. Yki-Jarvinen, Acute and chronic effects of hyperglycemia on glucose metabolism, Diabetologia 33 (1990) 579-585.
41. V. Poitout, R.P. Robertson, An integrated view of β-cell dysfunction in type II diabetes, Ann. Rev. Med. 47 (1996) 69-83.
42. M.J. Perley, D.M. Kipnis, Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects, J. Clin. Invest. 46 (1967) 1954-1962.
43. D.R. Matthews, A. Clark, β-Cell defects and pancreatic abnormalities in non-insulin dependent diabetes mellitus, in: J. Pickup, G. Williams (Eds.), Textbook of Diabetes, 2nd ed., vol. 1, Blackwell, Oxford, 1997, pp. 21.1-21.16.